Inhalable exosomes to target cardiac repair

Abstract

A recent study introduces Stem Cell-derived Exosome Nebulization Therapy (SCENT), a novel, non-invasive strategy that delivers lung spheroid cell-derived exosomes via inhalation to promote cardiac repair after myocardial infarction. This approach improves cardiac function, reduces injury, and demonstrates translational potential in both small and large animal models, offering a promising avenue for cell-free, inhalable regenerative therapies.

Keywords

Inhalation / exosomes / cardiovascular disease / CD36 / non-invasive delivery

References

[1] Li J,Zhu D.Inhalable stem cell exosomes promote heart repair after myocardial infarction.Circulation2024;150:710-23 PMCID:PMC11349039

[2] Garikipati VNS,Davis ME.Extracellular vesicles and the application of system biology and computational modeling in cardiac repair.Circ Res2018;123:188-204 PMCID:PMC6512976

[3] Adamiak M,Bobis-Wozowicz S.Induced pluripotent stem cell (iPSC)-derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs.Circ Res2018;122:296-309 PMCID:PMC5775034

[4] Khan M,Abramova T.Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction.Circ Res2015;117:52-64 PMCID:PMC4482130

[5] de Abreu RC, Fernandes H, da Costa Martins PA, Sahoo S, Emanueli C, Ferreira L. Native and bioengineered extracellular vesicles for cardiovascular therapeutics.Nat Rev Cardiol2020;17:685-97 PMCID:PMC7874903